4
Changes in Ownership
Immunocore Holdings plc Filed Acc 0001955244-25-000008
HEAD OF R&D sold 61,849 shares at $35.23 ($2,178,940)
- HEAD OF R&D acquired 61,849 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Berman David M · HEAD OF R&D
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +61,849 | $17.46 | $1,079,884 | 61,849 | D |
| 2025-09-30 | Sale : show line 2 in the form 10b5-1 | −61,849 | $35.23 | $2,178,940 | 0 | D |
| Open-market sales · 61,849 sh · avg $35.23 · $2,178,940 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Share Option (Right to Buy) | −61,849 | 136,790 | D |
Loading xslF345X05/form4-10022025_041002.xml…